BIOMAT Database Logo BIOMAT Database Logo

The factor VIII:C level is lower in daughters of hemophilia A subjects. 1981

R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski

UI MeSH Term Description Entries
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Lower factor VIII coagulant in daughters of subjects with hemophilia A compared to other obligate carriers.
April 1980, Blood,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency).
February 1984, Blood,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
March 1996, American journal of hematology,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Detection of hemophilia A carriers using intragenic factor VIII:C DNA polymorphisms.
May 1987, Blood,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
January 1985, Archivos de investigacion medica,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients.
December 2009, International journal of laboratory hematology,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors.
February 1988, Blood,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
A novel missense mutation in exon 4 of the factor VIII:C gene resulting in moderately severe hemophilia A.
December 1989, Blood,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
[Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
July 1991, Orvosi hetilap,
R A Henriksen, and C T Kisker, and P A Lachenbruch, and K P Hart, and A Zaleski
The 'in vivo' survival characteristics of factor VIII procoagulant antigen (VIII:C Ag) in haemophilia A subjects.
January 1982, Thrombosis research,
Copied contents to your clipboard!